A pilot study to establish an ovalbumin-induced atopic dermatitis minipig model

1Abdullahi A., Amini-Nik S., Jeschke M.G.: Animal models in burn research. Cell Mol Life Sci 2014, 71, 3241–3255, doi: 10.1007/s00018-014-1612-5. Abdullahi A. Amini-Nik S. Jeschke M.G. Animal models in burn research Cell Mol Life Sci 2014 71 3241 3255 10.1007/s00018-014-1612-5413442224714880Open DOISearch in Google Scholar

2Ansell D.M., Holden K.A., Hardman M.J.: Animal models of wound repair: Are they cutting it?, Exp Dermatol 2012, 21, 581–585, doi: 10.1111/j.1600-0625.2012.01540.x. Ansell D.M. Holden K.A. Hardman M.J. Animal models of wound repair: Are they cutting it? Exp Dermatol 2012 21 581 585 10.1111/j.1600-0625.2012.01540.x22775993Open DOISearch in Google Scholar

3Barbero A.M. Frasch H.F.: Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol In Vitro 2009, 23, 1–13, doi: 10.1016/j.tiv.2008.10.008. Barbero A.M. Frasch H.F. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review Toxicol In Vitro 2009 23 1 13 10.1016/j.tiv.2008.10.00819013230Open DOISearch in Google Scholar

4Bhogal R.K. Bona C.A.: Regulatory effect of extracellular signal-regulated kinases (ERK) on type I collagen synthesis in human dermal fibroblasts stimulated by IL-4 and IL-13. Int Rev Immunol 2008, 27, 472–496, doi: 10.1080/08830180802430974. Bhogal R.K. Bona C.A. Regulatory effect of extracellular signal-regulated kinases (ERK) on type I collagen synthesis in human dermal fibroblasts stimulated by IL-4 and IL-13 Int Rev Immunol 2008 27 472 496 10.1080/0883018080243097419065352Open DOISearch in Google Scholar

5Bieber T.: Atopic dermatitis. N Engl J Med 2008, 358, 1483–1494, doi: 10.1056/NEJMra074081. Bieber T. Atopic dermatitis N Engl J Med 2008 358 1483 1494 10.1056/NEJMra07408118385500Open DOISearch in Google Scholar

6Chan L.S., Robinson N., Xu L.: Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001, 117, 977–983, doi: 10.1046/j.0022-202x.2001.01484.x. Chan L.S. Robinson N. Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis J Invest Dermatol 2001 117 977 983 10.1046/j.0022-202x.2001.01484.x11676841Open DOISearch in Google Scholar

7Del Rosso J.Q.: Monoclonal Antibody Therapies for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management? J Clin Aesthet Dermatol 2019, 12, 39–41. Del Rosso J.Q. Monoclonal Antibody Therapies for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management? J Clin Aesthet Dermatol 2019 12 39 41Search in Google Scholar

8Dillon S.R., Sprecher C., Hammond A., Bilsborough J., Rosenfeld-Franklin M., Presnell S.R., Haugen H.S., Maurer M., Harder B., Johnston J., Bort S., Mudri S., Kuijper J.L., Bukowski T., Shea P., Dong D.L., Dasovich M., Grant F.J., Lockwood L., Levin S.D., LeCiel C., Waggie K., Day H., Topouzis S., Kramer J., Kuestner R., Chen Z., Foster D., Parrish-Novak J., Gross J.A.: Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004, 5, 752–760, doi: 10.1038/ni1084. Dillon S.R. Sprecher C. Hammond A. Bilsborough J. Rosenfeld-Franklin M. Presnell S.R. Haugen H.S. Maurer M. Harder B. Johnston J. Bort S. Mudri S. Kuijper J.L. Bukowski T. Shea P. Dong D.L. Dasovich M. Grant F.J. Lockwood L. Levin S.D. LeCiel C. Waggie K. Day H. Topouzis S. Kramer J. Kuestner R. Chen Z. Foster D. Parrish-Novak J. Gross J.A. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice Nat Immunol 2004 5 752 760 10.1038/ni108415184896Open DOISearch in Google Scholar

9Elias P.M.: Skin barrier function. Curr Allergy Asthma Rep 2008, 8, 299–305, doi: 10.1007/s11882-008-0048-0. Elias P.M. Skin barrier function Curr Allergy Asthma Rep 2008 8 299 305 10.1007/s11882-008-0048-0284341218606081Open DOISearch in Google Scholar

10Fukunaga A., Khaskhely N.M., Sreevidya C.S., Byrne S.N., Ullrich S.E.: Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response. J Immunol 2008, 180, 3057–3064, doi: 10.4049/jimmunol.180.5.3057. Fukunaga A. Khaskhely N.M. Sreevidya C.S. Byrne S.N. Ullrich S.E. Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response J Immunol 2008 180 3057 3064 10.4049/jimmunol.180.5.3057240837718292528Open DOISearch in Google Scholar

11Godin B.,Touitou E.: Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 2007, 59, 1152–1161, doi: 10.1016/j.addr.2007.07.004. Godin B.Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models Adv Drug Deliv Rev 2007 59 1152 1161 10.1016/j.addr.2007.07.00417889400Open DOISearch in Google Scholar

12Griffiths C.E., Esmann J., Fisher G.J., Voorhees J.J., Nickoloff B.J.: Differential modulation of keratinocyte intercellular adhesion molecule-I expression by gamma interferon and phorbol ester: evidence for involvement of protein kinase C signal transduction. Br J Dermatol 1990, 122, 333–42, doi: 10.1111/j.1365-2133.1990.tb08281.x. Griffiths C.E. Esmann J. Fisher G.J. Voorhees J.J. Nickoloff B.J. Differential modulation of keratinocyte intercellular adhesion molecule-I expression by gamma interferon and phorbol ester: evidence for involvement of protein kinase C signal transduction Br J Dermatol 1990 122 333 42 10.1111/j.1365-2133.1990.tb08281.xOpen DOISearch in Google Scholar

13Hammond S.A., Tsonis C., Sellins K., Rushlow K., Scharton-Kersten T., Colditz I., Glenn G.M.: Transcutaneous immunization of domestic animals: opportunities and challenges. Adv Drug Deliv Rev 2000, 43, 45–55, doi: 10.1016/s0169-409x(00)00076-4. Hammond S.A. Tsonis C. Sellins K. Rushlow K. Scharton-Kersten T. Colditz I. Glenn G.M. Transcutaneous immunization of domestic animals: opportunities and challenges Adv Drug Deliv Rev 2000 43 45 55 10.1016/s0169-409x(00)00076-4Open DOISearch in Google Scholar

14Howell M.D., Fairchild H.R., Kim B.E., Bin L., Boguniewicz M., Redzic J.S., Hansen K.C., Leung D.Y.: Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008, 128, 2248–2258, doi: 10.1038/jid.2008.74. Howell M.D. Fairchild H.R. Kim B.E. Bin L. Boguniewicz M. Redzic J.S. Hansen K.C. Leung D.Y. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation J Invest Dermatol 2008 128 2248 2258 10.1038/jid.2008.74Open DOISearch in Google Scholar

15Huang C.H., Kuo I.C., Xu H., Lee Y.S., Chua K.Y.: Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in mouse. J Invest Dermatol 2003, 121, 289–293, doi: 10.1046/j.1523-1747.2003.12356.x. Huang C.H. Kuo I.C. Xu H. Lee Y.S. Chua K.Y. Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in mouse J Invest Dermatol 2003 121 289 293 10.1046/j.1523-1747.2003.12356.xOpen DOISearch in Google Scholar

16Jin H., He R., Oyoshi M., Geha R.S.: Animal models of atopic dermatitis. J Invest Dermatol 2009, 129, 31–40, doi: 10.1038/jid.2008.106. Jin H. He R. Oyoshi M. Geha R.S. Animal models of atopic dermatitis J Invest Dermatol 2009 129 31 40 10.1038/jid.2008.106Open DOISearch in Google Scholar

17Jung Y., Son D., Kwon S., Kim J., Han K.: Experimental pig model of clinically relevant wound healing delay by intrinsic factors. Int Wound J 2013, 10, 295–305, doi: 10.1111/j.1742-481X.2012.00976.x. Jung Y. Son D. Kwon S. Kim J. Han K. Experimental pig model of clinically relevant wound healing delay by intrinsic factors Int Wound J 2013 10 295 305 10.1111/j.1742-481X.2012.00976.xOpen DOISearch in Google Scholar

18Kim B.E., Leung D.Y.M.: Significance of Skin Barrier Dysfunction in Atopic Dermatitis. Allergy Asthma Immunol Res 2018, 10, 207–215, doi: 10.4168/aair.2018.10.3.207. Kim B.E. Leung D.Y.M. Significance of Skin Barrier Dysfunction in Atopic Dermatitis Allergy Asthma Immunol Res 2018 10 207 215 10.4168/aair.2018.10.3.207Open DOISearch in Google Scholar

19Kim G.-D., Kim T.-H., Park Y.-S., Ahn H.-J., Cho J.-J., Park C.-S.: Immune response against 2,4-dinitrofluorobenzene-induced atopic dermatitis-like clinical manifestation is suppressed by spermidine in NC/Nga mice. Scand J Immunol 2015, 81, 221–228, doi: 10.1111/sji.12274. Kim G.-D. Kim T.-H. Park Y.-S. Ahn H.-J. Cho J.-J. Park C.-S. Immune response against 2,4-dinitrofluorobenzene-induced atopic dermatitis-like clinical manifestation is suppressed by spermidine in NC/Nga mice Scand J Immunol 2015 81 221 228 10.1111/sji.12274Open DOISearch in Google Scholar

20Kimura M., Tsuruta S., Yoshida T.: Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis. J Allergy Clin Immunol 1998, 101, 84–89, doi: 10.1016/S0091-6749(98)70197-6. Kimura M. Tsuruta S. Yoshida T. Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis J Allergy Clin Immunol 1998 101 84 89 10.1016/S0091-6749(98)70197-6Open DOISearch in Google Scholar

21Kubo A., Nagao K., Amagai M.: Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 2012, 122, 440–447, doi: 10.1172/JCI57416. Kubo A. Nagao K. Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases J Clin Invest 2012 122 440 447 10.1172/JCI57416326678022293182Open DOISearch in Google Scholar

22Kurihara-Bergstrom T., Woodworth M., Feisullin S., Beall P.: Characterization of the Yucatan miniature pig skin and small intestine for pharmaceutical applications. Lab Anim Sci 1986, 36, 396–399. Kurihara-Bergstrom T. Woodworth M. Feisullin S. Beall P. Characterization of the Yucatan miniature pig skin and small intestine for pharmaceutical applications Lab Anim Sci 1986 36 396 399Search in Google Scholar

23Lavker R.M., Dong G., Zheng P.S., Murphy G.F.: Hairless micropig skin. A novel model for studies of cutaneous biology. Am J Pathol 1991, 138, 687–697. Lavker R.M. Dong G. Zheng P.S. Murphy G.F. Hairless micropig skin A novel model for studies of cutaneous biology. Am J Pathol 1991 138 687 697Search in Google Scholar

24Leung D.Y., Bieber T.: Atopic dermatitis. Lancet 2003, 361, 151–160, doi: 10.1016/S0140-6736(03)12193-9. Leung D.Y. Bieber T. Atopic dermatitis Lancet 2003 361 151 160 10.1016/S0140-6736(03)12193-9Open DOISearch in Google Scholar

25Mahl J.A., Vogel B.E., Court M., Kolopp M., Roman D., Nogués V.: The minipig in dermatotoxicology: methods and challenges. Exp Toxicol Pathol 2006, 57, 341–345, doi: 10.1016/j.etp.2006.03.004. Mahl J.A. Vogel B.E. Court M. Kolopp M. Roman D. Nogués V. The minipig in dermatotoxicology: methods and challenges Exp Toxicol Pathol 2006 57 341 345 10.1016/j.etp.2006.03.00416713702Open DOISearch in Google Scholar

26Man M.Q., Hatano Y., Lee S.H., Man M., Chang S., Feingold K.R., Leung D.Y., Holleran W., Uchida Y., Elias P.M.: Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 2008, 128, 79–86, doi: 10.1038/sj.jid.5701011. Man M.Q. Hatano Y. Lee S.H. Man M. Chang S. Feingold K.R. Leung D.Y. Holleran W. Uchida Y. Elias P.M. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges J Invest Dermatol 2008 128 79 86 10.1038/sj.jid.5701011267122917671515Open DOISearch in Google Scholar

27Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J., Matsumoto M., Ushio H., Saito S., Askenase P.W., Ra C.: Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997, 9, 461–466, doi: 10.1093/intimm/9.3.461. Matsuda H. Watanabe N. Geba G.P. Sperl J. Tsudzuki M. Hiroi J. Matsumoto M. Ushio H. Saito S. Askenase P.W. Ra C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice Int Immunol 1997 9 461 466 10.1093/intimm/9.3.4619088984Open DOISearch in Google Scholar

28Matsumoto K., Mizukoshi K., Oyobikawa M., Ohshima H., Tagami H.: Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments. Skin Res Technol 2004, 10, 122–129, doi: 10.1111/j.1600-0846.2004.00062.x. Matsumoto K. Mizukoshi K. Oyobikawa M. Ohshima H. Tagami H. Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments Skin Res Technol 2004 10 122 129 10.1111/j.1600-0846.2004.00062.x15059180Open DOISearch in Google Scholar

29Meyer W., Schwarz R., Neurand K.: The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Curr Probl Dermatol 1978, 7, 39–52, doi: 10.1159/000401274. Meyer W. Schwarz R. Neurand K. The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig Curr Probl Dermatol 1978 7 39 52 10.1159/000401274752456Open DOISearch in Google Scholar

30Michels G.M., Walsh K.F., Kryda K.A., Mahabir S.P., Walters R.R., Hoevers J.D., Martinon O.M.: A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis. Vet Dermatol 2016, 27, 505–e136, doi: 10.1111/vde.12364. Michels G.M. Walsh K.F. Kryda K.A. Mahabir S.P. Walters R.R. Hoevers J.D. Martinon O.M. A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis Vet Dermatol 2016 27 505 e136 10.1111/vde.1236427647513Open DOISearch in Google Scholar

31Mori T., Kabashima K., Yoshiki R., Sugita K., Shiraishi N., Onoue A., Kuroda E., Kobayashi M., Yamashita U., Tokura Y.: Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokines. J Invest Dermatol 2008, 128, 1719–1727, doi: 10.1038/jid.2008.5. Mori T. Kabashima K. Yoshiki R. Sugita K. Shiraishi N. Onoue A. Kuroda E. Kobayashi M. Yamashita U. Tokura Y. Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokines J Invest Dermatol 2008 128 1719 1727 10.1038/jid.2008.518239613Open DOISearch in Google Scholar

32Moyaert H., Van Brussel L., Borowski S., Escalada M., Mahabir S.P., Walters R.R., Stegemann M.R.: A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis. Vet Dermatol 2017, 28, 593–e145, doi: 10.1111/vde.12478. Moyaert H. Van Brussel L. Borowski S. Escalada M. Mahabir S.P. Walters R.R. Stegemann M.R. A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis Vet Dermatol 2017 28 593 e145 10.1111/vde.1247828906040Open DOISearch in Google Scholar

33Novak N., Bieber T., Leung D.Y.: Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003, 112, S128–139, doi: 10.1016/j.jaci.2003.09.032. Novak N. Bieber T. Leung D.Y. Immune mechanisms leading to atopic dermatitis J Allergy Clin Immunol 2003 112 S128 139 10.1016/j.jaci.2003.09.03214657843Open DOISearch in Google Scholar

34Oyoshi M.K., He R., Kumar L., Yoon J., Geha R.S.: Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol 2009, 102, 135–226, doi: 10.1016/S0065-2776(09)01203-6. Oyoshi M.K. He R. Kumar L. Yoon J. Geha R.S. Cellular and molecular mechanisms in atopic dermatitis Adv Immunol 2009 102 135 226 10.1016/S0065-2776(09)01203-6Open DOISearch in Google Scholar

35Oyoshi M.K., Murphy G.F., Geha R.S.: Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol 2009, 124, 485–493, 493.e1, doi: 10.1016/j.jaci.2009.05.042v. Oyoshi M.K. Murphy G.F. Geha R.S. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen J Allergy Clin Immunol 2009 124 485 493 493.e1 10.1016/j.jaci.2009.05.042vOpen DOISearch in Google Scholar

36Paller A., Jaworski J.C., Simpson E.L., Boguniewicz M., Russell J.J., Block J.K., Tofte S., Dunn J.D., Feldman S.R., Clark A.R., Schwartz G., Eichenfield L.F.: Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders. Am J Clin Dermatol 2018, 19, 821–838, doi: 10.1007/s40257-018-0383-4. Paller A. Jaworski J.C. Simpson E.L. Boguniewicz M. Russell J.J. Block J.K. Tofte S. Dunn J.D. Feldman S.R. Clark A.R. Schwartz G. Eichenfield L.F. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders Am J Clin Dermatol 2018 19 821 838 10.1007/s40257-018-0383-4Open DOISearch in Google Scholar

37Pastore S., Corinti S., La Placa M., Didona B., Girolomoni G.: Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J Allergy Clin Immunol 1998, 101, 538–544, doi: 10.1016/S0091-6749(98)70361-6. Pastore S. Corinti S. La Placa M. Didona B. Girolomoni G. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis J Allergy Clin Immunol 1998 101 538 544 10.1016/S0091-6749(98)70361-6Open DOISearch in Google Scholar

38Silverberg J.I.: Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy 2015, 70, 1300–1308, doi: 10.1111/all.12685. Silverberg J.I. Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies Allergy 2015 70 1300 1308 10.1111/all.1268526148129Open DOISearch in Google Scholar

39Souza C.P., Rosychuk R.A.W., Contreras E.T., Schissler J.R., Simpson A.C.: A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA. Vet Dermatol 2018, 29, 489–e164, doi: 10.1111/vde.12682. Souza C.P. Rosychuk R.A.W. Contreras E.T. Schissler J.R. Simpson A.C. A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA Vet Dermatol 2018 29 489 e164 10.1111/vde.1268230141223Open DOISearch in Google Scholar

40Spergel J.M., Mizoguchi E., Brewer J.P., Martin T.R., Bhan A.K., Geha R.S.: Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998, 101, 1614–1622, doi: 10.1172/JCI1647. Spergel J.M. Mizoguchi E. Brewer J.P. Martin T.R. Bhan A.K. Geha R.S. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice J Clin Invest 1998 101 1614 1622 10.1172/JCI16475087429541491Open DOISearch in Google Scholar

41Szczepanik M.P., Popiel J., Cekiera A., Pomorska-Handwerker D., Karaś-Tęcza J., Ściskalska M., Oczkowska K., Taube M., Olender V., Parys P.: Evaluation of the clinical efficiency of lokivetmab in client privately owned atopic dogs - multicenter study. Pol J Vet Sci 2020, 23, 191–195, doi: 10.24425/pjvs.2020.132765. Szczepanik M.P. Popiel J. Cekiera A. Pomorska-Handwerker D. Karaś-Tęcza J. Ściskalska M. Oczkowska K. Taube M. Olender V. Parys P. Evaluation of the clinical efficiency of lokivetmab in client privately owned atopic dogs - multicenter study Pol J Vet Sci 2020 23 191 195 10.24425/pjvs.2020.13276532627992Open DOISearch in Google Scholar

42Szczepanik M.P., Wikolek P., Goynski M., Sitkowski W., Taszkun I., Toczek W.: The influence of treatment with lokivetmab on transepidermal water loss (TEWL) in dogs with spontaneously occurring atopic dermatitis. Vet Dermatol 2019, 30, 330–e93, doi: 10.1111/vde.12758. Szczepanik M.P. Wikolek P. Goynski M. Sitkowski W. Taszkun I. Toczek W. The influence of treatment with lokivetmab on transepidermal water loss (TEWL) in dogs with spontaneously occurring atopic dermatitis Vet Dermatol 2019 30 330 e93 10.1111/vde.1275831090122Open DOISearch in Google Scholar

43Tamamoto-Mochizuki C., Paps J.S., Olivry T.: Proactive maintenance therapy of canine atopic dermatitis with the anti-IL-31 lokivetmab. Can a monoclonal antibody blocking a single cytokine prevent allergy flares?, Vet Dermatol 2019, 30, 98, doi: 10.1111/vde.12715. Tamamoto-Mochizuki C. Paps J.S. Olivry T. Proactive maintenance therapy of canine atopic dermatitis with the anti-IL-31 lokivetmab Can a monoclonal antibody blocking a single cytokine prevent allergy flares?, Vet Dermatol 2019 30 98 10.1111/vde.1271530672050Open DOISearch in Google Scholar

44Vana G., Meingassner J.G.: Morphologic and immunohistochemical features of experimentally induced allergic contact dermatitis in Göttingen minipigs. Vet Pathol 2000, 37, 565–580, doi: 10.1354/vp.37-6-565. Vana G. Meingassner J.G. Morphologic and immunohistochemical features of experimentally induced allergic contact dermatitis in Göttingen minipigs Vet Pathol 2000 37 565 580 10.1354/vp.37-6-56511105946Open DOISearch in Google Scholar

45Vardaxis N.J., Brans T.A., Boon M.E., Kreis R.W., Marres L.M.: Confocal laser scanning microscopy of porcine skin: implications for human wound healing studies. J Anat 1997, 190, 601–611, doi: 10.1046/j.1469-7580.1997.19040601.x. Vardaxis N.J. Brans T.A. Boon M.E. Kreis R.W. Marres L.M. Confocal laser scanning microscopy of porcine skin: implications for human wound healing studies J Anat 1997 190 601 611 10.1046/j.1469-7580.1997.19040601.x14676449183682Open DOISearch in Google Scholar